ATE136032T1 - 8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate - Google Patents

8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate

Info

Publication number: ATE136032T1
Authority: AT; Austria
Prior art keywords: atoms; group; groups; alkyl; substituted
Prior art date: 1987-07-20

Application number

AT88201418T

Other languages

English (en)

Inventor

Derk Hamminga

Wijngaarden Ineke Van

Johannes Wilhelmus Jansen

Original Assignee

Duphar Int Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-20

Filing date

1988-07-07

Publication date

1996-04-15

1988-07-07 Application filed by Duphar Int Res filed Critical Duphar Int Res

1996-04-15 Application granted granted Critical

1996-04-15 Publication of ATE136032T1 publication Critical patent/ATE136032T1/de

Links

CFTOTSJVQRFXOF-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole Chemical class N1C2=CC=CC=C2C2=C1CNCC2 CFTOTSJVQRFXOF-UHFFFAOYSA-N 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 59
125000000217 alkyl group Chemical group 0.000 abstract 29
125000003545 alkoxy group Chemical group 0.000 abstract 18
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 10
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 9
125000001153 fluoro group Chemical group F* 0.000 abstract 8
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 6
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 6
125000006413 ring segment Chemical group 0.000 abstract 6
125000000753 cycloalkyl group Chemical group 0.000 abstract 5
229910052736 halogen Inorganic materials 0.000 abstract 5
229910052739 hydrogen Inorganic materials 0.000 abstract 5
239000001257 hydrogen Substances 0.000 abstract 5
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 5
125000003342 alkenyl group Chemical group 0.000 abstract 4
125000004414 alkyl thio group Chemical group 0.000 abstract 4
125000000304 alkynyl group Chemical group 0.000 abstract 4
125000004093 cyano group Chemical group *C#N 0.000 abstract 4
125000005842 heteroatom Chemical group 0.000 abstract 4
125000000623 heterocyclic group Chemical group 0.000 abstract 4
125000004183 alkoxy alkyl group Chemical group 0.000 abstract 3
229910052799 carbon Inorganic materials 0.000 abstract 3
150000002367 halogens Chemical group 0.000 abstract 3
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 3
229910052757 nitrogen Inorganic materials 0.000 abstract 3
125000004433 nitrogen atom Chemical group N* 0.000 abstract 3
RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 3
125000002837 carbocyclic group Chemical group 0.000 abstract 2
125000000000 cycloalkoxy group Chemical group 0.000 abstract 2
125000005366 cycloalkylthio group Chemical group 0.000 abstract 2
230000003480 fibrinolytic effect Effects 0.000 abstract 2
125000005843 halogen group Chemical group 0.000 abstract 2
229910052760 oxygen Inorganic materials 0.000 abstract 2
229910052717 sulfur Inorganic materials 0.000 abstract 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
229910019950 S—O Inorganic materials 0.000 abstract 1
125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 1
125000005079 alkoxycarbonylmethyl group Chemical group 0.000 abstract 1
125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
125000002619 bicyclic group Chemical group 0.000 abstract 1
125000001589 carboacyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000002950 monocyclic group Chemical group 0.000 abstract 1
125000003884 phenylalkyl group Chemical group 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT88201418T 1987-07-20 1988-07-07 8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate ATE136032T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL8701709		1987-07-20

Publications (1)

Publication Number	Publication Date
ATE136032T1 true ATE136032T1 (de)	1996-04-15

Family

ID=19850345

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88201418T ATE136032T1 (de)	1987-07-20	1988-07-07	8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate

Country Status (11)

Country	Link
US (1)	US5100884A (de)
EP (1)	EP0300541B1 (de)
JP (1)	JPS6434984A (de)
AT (1)	ATE136032T1 (de)
AU (1)	AU613059B2 (de)
CA (1)	CA1338189C (de)
DE (1)	DE3855147D1 (de)
DK (1)	DK395888A (de)
IL (1)	IL87150A (de)
NZ (1)	NZ225421A (de)
ZA (1)	ZA885146B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0347980A1 (de) *	1988-06-20	1989-12-27	Duphar International Research B.V	8,9-Anellierte B-Carboline und 8,9-anellierte 3,4-dihydro-B-Carboline
EP0357122A3 (de) *	1988-08-29	1991-10-23	Duphar International Research B.V	Verwendung von Beta-Carbolinen und deren bio-isosterischen Benzofuran- und Benzothiophenanalogen zur Herstellung eines Arzneimittels mit cytostatischer Wirkung
EP0377238A1 (de) *	1988-12-22	1990-07-11	Duphar International Research B.V	Annelierte Indolo(3,2-c)-lactame
EP0380155A1 (de) *	1989-01-19	1990-08-01	Duphar International Research B.V	8,9-Annelierte-1,2,3,4-tetrahydro-beta-carboline-Derivate
FR2663935A1 (fr) *	1990-06-27	1992-01-03	Adir	Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ314105A (en) *	1996-02-02	1997-12-19	Sumitomo Pharma	Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
MXPA01012914A (es)	1999-06-15	2004-04-21	Bristol Myers Squibb Co	Gama-carbolinas fundidas de heterociclo substituido.
US7071186B2 (en)	1999-06-15	2006-07-04	Bristol-Myers Squibb Pharma Co.	Substituted heterocycle fused gamma-carbolines
US6713471B1 (en)	1999-06-15	2004-03-30	Bristol-Myers Squibb Pharma Company	Substituted heterocycle fused gamma-carbolines
US6858599B2 (en)	1999-06-30	2005-02-22	Mochida Pharmaceutical Co., Ltd.	Tricyclic compound having spiro union
PL352862A1 (en) *	1999-06-30	2003-09-08	Mochida Pharmaceutical Co, Ltd.	Tricyclic compounds having spiro union
UA74826C2 (en)	2000-05-17	2006-02-15	Ortho Mcneil Pharm Inc	?-carboline derivatives as phosphodiesterase inhibitors
MXPA03005438A (es)	2000-12-20	2004-05-05	Bristol Myers Squibb Co	Pirioindoles substituidos como agonistas y antagonistas de serotonina.
US6849619B2 (en) *	2000-12-20	2005-02-01	Bristol-Myers Squibb Company	Substituted pyridoindoles as serotonin agonists and antagonists
JP2007518822A (ja)	2004-01-23	2007-07-12	カイロンコーポレイション	抗癌剤としてのテトラヒドロカルボリン化合物
US8076352B2 (en)	2004-03-15	2011-12-13	Ptc Therapeutics, Inc.	Administration of carboline derivatives useful in the treatment of cancer and other diseases
US8076353B2 (en)	2004-03-15	2011-12-13	Ptc Therapeutics, Inc.	Inhibition of VEGF translation
ZA200608176B (en)	2004-03-15	2008-05-28	Ptc Therapeutics Inc	Carboline derivatives useful in the inhibition of angiogenesis
US7767689B2 (en)	2004-03-15	2010-08-03	Ptc Therapeutics, Inc.	Carboline derivatives useful in the treatment of cancer
WO2011082266A2 (en)	2009-12-30	2011-07-07	Arqule, Inc.	Substituted heterocyclic compounds
DE102019128072B4 (de)	2019-10-17	2021-11-18	Infineon Technologies Ag	Transistorbauelement mit einem variierenden flächenbezogenen spezifischen gaterunnerwiderstand

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3299078A (en) *	1962-10-01	1967-01-17	Smith Kline French Lab	Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
EP0017727A1 (de) *	1979-04-10	1980-10-29	Ciba-Geigy Ag	Polysubstituierte Diazatricyclen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0185429A1 (de) *	1984-12-21	1986-06-25	Duphar International Research B.V	Bizyklische Piperazine
DK686688A (da) *	1987-12-14	1989-06-15	Duphar Int Res	8,9-annelerede beta-carboliner, deres fremstilling og laegemidler indeholdende forbindelserne
EP0357122A3 (de) *	1988-08-29	1991-10-23	Duphar International Research B.V	Verwendung von Beta-Carbolinen und deren bio-isosterischen Benzofuran- und Benzothiophenanalogen zur Herstellung eines Arzneimittels mit cytostatischer Wirkung

1988
- 1988-07-07 EP EP88201418A patent/EP0300541B1/de not_active Expired - Lifetime
- 1988-07-07 DE DE3855147T patent/DE3855147D1/de not_active Expired - Lifetime
- 1988-07-07 AT AT88201418T patent/ATE136032T1/de not_active IP Right Cessation
- 1988-07-15 NZ NZ225421A patent/NZ225421A/en unknown
- 1988-07-15 ZA ZA885146A patent/ZA885146B/xx unknown
- 1988-07-15 DK DK395888A patent/DK395888A/da not_active Application Discontinuation
- 1988-07-15 CA CA000572113A patent/CA1338189C/en not_active Expired - Fee Related
- 1988-07-18 JP JP63177252A patent/JPS6434984A/ja active Pending
- 1988-07-18 IL IL87150A patent/IL87150A/xx not_active IP Right Cessation
- 1988-07-18 AU AU19152/88A patent/AU613059B2/en not_active Ceased
1989
- 1989-10-30 US US07/428,481 patent/US5100884A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU613059B2 (en)	1991-07-25
AU1915288A (en)	1989-01-27
NZ225421A (en)	1991-03-26
EP0300541B1 (de)	1996-03-27
IL87150A (en)	1992-12-01
DK395888A (da)	1989-01-21
JPS6434984A (en)	1989-02-06
IL87150A0 (en)	1988-12-30
ZA885146B (en)	1989-03-29
US5100884A (en)	1992-03-31
DE3855147D1 (de)	1996-05-02
EP0300541A1 (de)	1989-01-25
DK395888D0 (da)	1988-07-15
CA1338189C (en)	1996-03-26

Legal Events

Date	Code	Title	Description
1996-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE136032T1 (de)	1996-04-15	8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate
ATE7300T1 (de)	1984-05-15	Alkylierte verbindungen von c-076-verbindungen, verfahren zu deren herstellung und deren verwendung als antiparasitische mittel.
ATE144772T1 (de)	1996-11-15	Piperazinderivate
KR890001553A (ko)	1989-03-27	약학적 조성물
DE2966344D1 (en)	1983-12-01	Xanthone and thioxanthone derivatives, their preparation and pharmaceutical compositions containing them
EP0414422A3 (en)	1991-07-24	2-oxo-1-oxa-8-azaspiro (4,5) decane derivatives, processes for their preparation and pharmaceutical compositions thereof
PT88991A (pt)	1988-12-01	Processo para a preparacao de analogos de avermectinas e milbemicinas
PT91607A (pt)	1990-03-30	Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
ATE27817T1 (de)	1987-07-15	Phenylpiperazin-derivate und verfahren zu deren herstellung.
ATE154351T1 (de)	1997-06-15	2,3-diphenyl-5-pyrrolyl-furan derivate, verfahren und zwischenprodukte für ihre herstellung und ihre verwendung als entzündungshemmende, antiallergische und blutplättchenaggregationshemmende mittel
ATE120744T1 (de)	1995-04-15	Azolderivate und diese enthaltende antiulcus- zusammensetzungen.
ES498960A0 (es)	1982-04-16	Procedimiento para preparar esteres de 2-nitro-5-fenoxi sustituido)benzoato de alfa-hidroxialcanoatos
ATE269329T1 (de)	2004-07-15	Neue basische derivate von benz(e)isoindol-1-onen und pyrrolo(3,4-c)chinolin-1-onen mit 5-ht3- antagonistischer aktivität, ihre herstellung und ihre therapeutische verwendung
ATE78689T1 (de)	1992-08-15	Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums.
ES8602712A1 (es)	1985-12-01	Un procedimiento para preparar un derivado de rodanina
DE3854205D1 (de)	1995-08-24	Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung.
ES2032214T3 (es)	1993-01-16	Un procedimiento para la preparacion de un derivado de ergolina.
HUT60261A (en)	1992-08-28	Process for producing piperazine derivatives and pharmaceutical compositions comprising same
ES8207181A1 (es)	1982-09-01	Procedimiento para la fabricacion de derivados de 5,6,7,7atetrahidro-4h-tieno(3,2-c)-piridin-2-ona .
ATE6652T1 (de)	1984-03-15	Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
NZ218034A (en)	1989-07-27	Benzopyrando(2,3-c)pyrrole derivatives, intermediates and pharmaceutical compositions
JPS5610191A (en)	1981-02-02	Clavulanic acid derivative* its manufacture and composition
KR830001293A (ko)	1983-04-30	7-아미노티아졸릴아세트 아미도 세팔로스포라닉산으로 부터 유도된 생성물 제조에 대한 새로운 공정
KR830001215A (ko)	1983-04-29	불소가 함유된 1.4-디하이드로피리딘 화합물의 제조방법